Overview

Vitamin D Supplementation to Patients With Type 2 Diabetes

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to evaluate if supplementation with vitamin D in a dose of 40.000 IU per week will result in improved metabolic control in patients with type 2 diabetes.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Tromso
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins
Criteria
Inclusion Criteria:

- Type 2 diabetes for at least 1 year

- age 21-75 years

- long-acting insulin at bedtime

- metformin during the day

- for women of child bearing age use of reliable method of birth control

Exclusion Criteria:

- serum creatinine above 130 umol/l for men and above 110 for women

- systolic blood pressure > 175 or diastolic > 104 mmHg

- heart disease

- serum calcium > 2.54 mmol/l

- history of renal stones